{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-133170","form_type":"8-K","ticker":"TYRA","cik":"0001863127","company_name":"Tyra Biosciences, Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.959958+00:00","generated_at":"2026-06-02T20:37:56.724793+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Tyra Biosciences appoints Drs. Moran and Rothenberg to Board; Dr. Chen resigns","bullets":["Isan Chen resigned from Board and Compensation Committee effective May 7, 2024, with no disagreement.","Board expanded from nine to ten and appointed Susan Moran (former CMO, RayzeBio) and S. Michael Rothenberg (CMO, insitro) as directors.","Moran appointed to Compensation and Science/Technology Committees; Rothenberg to Science/Technology Committee.","Each new director received options for 37,200 shares vesting over 36 months plus cash compensation.","Both directors are deemed independent under Nasdaq listing standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-133170","json":"https://secwatch.observer/filing/0001193125-24-133170.json","markdown":"https://secwatch.observer/filing/0001193125-24-133170.md","text":"https://secwatch.observer/filing/0001193125-24-133170.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1863127/000119312524133170/0001193125-24-133170-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1863127/000119312524133170/d822217d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T20:37:56.724793+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c9fa3a1db","claim":"S. Michael Rothenberg was appointed as Director at Tyra Biosciences, Inc..","evidence_excerpt":"appointed Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312524133170/0001193125-24-133170-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"997e1d3464","claim":"Susan Moran was appointed as Director at Tyra Biosciences, Inc..","evidence_excerpt":"appointed Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312524133170/0001193125-24-133170-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b35ea3f8a2","claim":"Isan Chen resigned as Director at Tyra Biosciences, Inc..","evidence_excerpt":"Isan Chen, M.D. resigned from the Board and the Compensation Committee of the Board effective as of May 7, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312524133170/0001193125-24-133170-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}